Michael Har-Noy

67 %
33 %
Information about Michael Har-Noy
Business-Finance

Published on April 26, 2014

Author: viewdocs

Source: authorstream.com

PowerPoint Presentation: Michael Har-Noy Founder and CEO of Immunovative Therapies, Ltd PowerPoint Presentation: Studying AlloStimTM Along With Chaperone Rich Protein Lysate Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., says that the power of the human immune system can be successfully harnessed to kill malignant tumors and to prevent their recurrence. Dr. Michael Har-Noy says that preliminary data indicates that AlloStimTM, his company’s lead product, has powerful anti-tumor activity against a wide range of malignancies. Dr. Michael Har-Noy is now conducting a Phase I/II trial that combine AlloStimTM with Chaperone Rich Protein Lysate (CRCL). He hopes this combination will both eradicate malignant tumors and prevent their recurrence. More information about Dr. Michael Har-Noy’s landmark phase I/II trial of CRCL-AlloVaxTM can be found at www.immunocare.net . Compassionate Use Program Is Underway In Bangkok, Thailand: Compassionate Use Program Is Underway In Bangkok, Thailand Dr. Michael Har-Noy, Immunovative Therapies Ltd.’s CEO and founder, says that patients with metastatic cancer that have exhausted all conventional treatment options may qualify for treatment using his company’s unique biologic products. Dr. Michael Har-Noy indicates that his Compassionate Use program in Bangkok, Thailand is being conducted along with a phase I/II trial of CRCL-AlloVaxTM, one of his company’s leading drugs. Dr. Michael Har-Noy is also testing the drug AlloStimTM in HIV positive patients. Interested parties should visit the website, www.immunocare.net , for more information. PowerPoint Presentation: Proprietary Drugs May Be Effective Against Many Different Cancers Preliminary data show that AlloStimTM and CRCL-AlloVaxTM, two proprietary compounds developed by Dr. Michael Har-Noy, have activity against a wide variety of malignancies. Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., a biotechnology company in Israel, says that he is planning phase I/II trials of AlloStimTM in hepatocellular carcinoma and in head and neck malignancies. Dr. Michael Har-Noy is also designing phase II/III marketing trials for his drugs in patients with HER2+ breast cancer and KRAS gene positive colon cancer. Please visit www.immunocare.net for more information. PowerPoint Presentation: http://michaelhar-noy.brandyourself.com/

Add a comment

Related presentations

Related pages

Dr. Michael Har-Noy and Immunovative Therapies, Ltd.

Dr. Michael Har-Noy and Immunovative Therapies, Ltd. Site Developed by Enthusiasts of Spreading the Word about Immunovative Therapies, Ltd. and its ...
Read more

Michael Har-Noy - Shoham, HaMerkaz, Israel, Founder Of ...

View Michael Har-Noy on about.me, your personal page with a purpose. Michael Har-Noy uses about.me to show people what matters most to them.
Read more

Michael Har-Noy | LinkedIn

Michael Har-Noy. Founder and CEO of Immunovative Therapies, Ltd . Location Ramla Area, Israel Industry Health, Wellness and Fitness
Read more

Michael Har-Noy | Free Listening on SoundCloud

Dr. Michael Har-Noy and his company, Immunovative Therapies Ltd., create new and unique treatments for cancer. Dr. Michael Har-Noy has spent his entire ...
Read more

About Us | Dr. Michael Har-Noy and Immunovative Therapies ...

About Us. About Immunovative Therapies, Ltd. and Dr. Michael Har-Noy. For the official Immunovative Therapies, Ltd. corporate website, please visit www ...
Read more

Michael Har-Noy on Behance

Dr. Michael Har-Noy is a gifted scientist who founded Immunovative Therapies, Ltd. in Israel in 2004. After many years of immunology research, he has ...
Read more

Michael Har-Noy | Dr. Michael Har-Noy Working Towards ...

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., a biotech company in Israel, has developed a unique biologic, AlloStimTM, which ...
Read more

Michael Har-Noy: Executive Profile & Biography - Bloomberg.com

Dr. Michael Har-Noy is the Founder of Immunovative Therapies Ltd., and serves as its Chief Executive Officer. Dr. Har-Noy has over 25 years of experience ...
Read more

Michael Har-Noy - Founder - Immunovative Therapies, Ltd ...

Ähnliche XING-Profile wie das von Michael Har-Noy. Adriaan Kleingeld Owner & Founder (Co Founder) Cluj Napoca Umit Gurel Founder ...
Read more

Michael Har-Noy (Hadassah Medical Center, Jerusalem) on ...

Michael Har-Noy of Hadassah Medical Center, Jerusalem with expertise in Clinical Immunology, Clinical Trials, Cancer Research is on ResearchGate. Read 9 ...
Read more